Sex Differences in the Effectiveness of Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Sacubitril–Valsartan for the Treatment of Heart Failure

BACKGROUND: PARAGON‐HF (Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction) suggested a potential benefit of sacubitril–valsartan in women with preserved ejection fraction. Among patients with heart failure previ...

Descripción completa

Detalles Bibliográficos
Autores principales: Sohani, Zahra N., Behlouli, Hassan, de Moura, Cristiano Soares, Abrahamowicz, Michal, Pilote, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382087/
https://www.ncbi.nlm.nih.gov/pubmed/37421275
http://dx.doi.org/10.1161/JAHA.122.028865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382087/
https://www.ncbi.nlm.nih.gov/pubmed/37421275
http://dx.doi.org/10.1161/JAHA.122.028865

Ejemplares similares